Skip to search formSkip to main contentSkip to account menu

1.5 ML Somatropin 6.67 MG/ML Pen Injector [Norditropin]

Known as: Norditropin 10 MG per 1.5 ML Pen Injector, SOMATROPIN 10MG FLEXPRO 1.5ML, Norditropin 10 MG in 1.5 ML Pen Injector 
National Institutes of Health

Related topics

Related topics

21 relations
Brain NeoplasmsCachexiaCongestive heart failureDrug Allergy

Broader (1)

Pituitary Hormones, Anterior

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Efficacy and safety of two doses of Norditropin® (somatropin) in short stature due to Noonan syndrome: a 2-year randomized, double-blind, multicenter trial in Japanese patients.
This randomized double-blind multicenter trial (NCT01927861) evaluated the growth-promoting effect and safety of Norditropin… 
2015
2015
An analysis of product wastage arising from dosing increment granularity in four modern growth hormone administration devices
Objective: Human growth hormone (hGH) delivery systems differ in the size of the dose increments that can be set by the patient… 
2014
2014
Evaluation of the Safety and Usability of FlexPro ® 30 mg/3 ml, for the Delivery of Norditropin ® in Patients Requiring GH Therapy
2014
2014
PO2-22: Usability and safety of FlexPro® PenMate®, a growth hormone (GH) injection system, in patients, caregivers and healthcare professionals
2013
2013
The E ffi cacy and Safety of Long-term Norditropin ® Treatment in Children with Prader-Willi Syndrome
which a ff ects between 1:20 000 and 1:30 000 live births [ 1 , 2 ] , is a complex neurodevelopmental disorder caused by defects… 
2013
2013
The Efficacy and Safety of Long-term Norditropin® Treatment in Children with Prader-Willi Syndrome
Abstract Prader-Willi syndrome is a genetic disorder that is associated with short stature, partial growth hormone deficiency… 
Review
2013
Review
2013
Assessment of user-friendliness of the Norditropin FlexPro for pediatric patients treated with recombinant human growth hormone: results of an open-label user survey
Abstract Objective: To assess the user-friendliness of the Norditropin FlexPro (Novo Nordisk A/S, Bagsvaerd, Denmark), a newly… 
Review
2013
Review
2013
Comparison of injection dose force, accuracy and precision among three growth hormone injection devices
Successful growth hormone (GH) therapy requires sustained treatment adherence, usually over long periods of time. However… 
2013
2013
ff ect of Exercise on Circulating Levels of Brain-derived Neurotrophic Factor ( BDNF ) in Overweight and Obese Subjects
▼ Exercise increases the expression of brainderived neurotrophic factor (BDNF) in rodents and in healthy humans. Its relationship… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)